Format

Send to:

Choose Destination
See comment in PubMed Commons below
Neuroimage. 2014 Feb 1;86:306-10. doi: 10.1016/j.neuroimage.2013.10.004. Epub 2013 Oct 10.

Decreased norepinephrine transporter availability in obesity: Positron Emission Tomography imaging with (S,S)-[(11)C]O-methylreboxetine.

Author information

  • 1Department of Psychiatry, Yale University, New Haven, CT, USA; Department of Neurobiology, Yale University, New Haven, CT, USA; Interdepartmental Neuroscience Program, Yale University, New Haven, CT, USA.
  • 2Department of Psychiatry, Yale University, New Haven, CT, USA; Department of Neurobiology, Yale University, New Haven, CT, USA; Child Study Center, Yale University, New Haven, CT, USA.
  • 3Department of Diagnostic Radiology, Yale University, New Haven, CT, USA.
  • 4Department of Psychiatry, Yale University, New Haven, CT, USA.
  • 5Department of Psychiatry, Yale University, New Haven, CT, USA; Child Study Center, Yale University, New Haven, CT, USA.
  • 6Department of Diagnostic Radiology, Yale University, New Haven, CT, USA; Department of Psychiatry and Radiology, New York University, New York, NY, USA.
  • 7Department of Diagnostic Radiology, Yale University, New Haven, CT, USA; Department of Biomedical Engineering, Yale University, New Haven, CT, USA.
  • 8Department of Psychiatry and Radiology, New York University, New York, NY, USA. Electronic address: Alexander.Neumeister@nyumc.org.

Abstract

OBJECTIVES:

Noradrenergic dysfunction is implicated in obesity. The norepinephrine transporter (NET) regulates the synaptic availability of norepinephrine. However, NET availability has not been previously characterized in vivo in obese people using Positron Emission Tomography (PET) imaging. Here we report findings evaluating NET availability in individuals with obesity and matched lean (i.e., normal weight) comparison subjects.

METHODS:

Seventeen obese but otherwise healthy individuals with a mean±SD body mass index (BMI) of 34.7±2.6 and 17 lean individuals with a mean±SD BMI of 23.1±1.4 were studied using a high-resolution research tomograph (HRRT) and (S,S)-[(11)C]O-methylreboxetine ([(11)C]-MRB), a radioligand selective for the NET. The regional brain NET binding potential (BPND) was estimated by the multilinear reference tissue model 2 (MRTM2) with the occipital cortex as a reference region. BPND for regions of interest were obtained with the Automated Anatomic Labeling (AAL) template registered to individual's structural MR scans.

RESULTS:

Obese individuals had lower NET BPND values in the thalamus (p<0.038, 27% reduction) including within the pulvinar (p<0.083, 30% reduction), but not in the hypothalamus, locus coeruleus or the raphe nuclei, compared to lean individuals. When age was included as a covariate, the difference in NET BPND values remained significant in the thalamus (p<0.025) and pulvinar (p<0.042).

CONCLUSIONS:

These results indicate that NET availability is decreased in the thalamus, including the pulvinar, in obese individuals. These findings further support data indicating noradrenergic dysfunction in obesity and suggest impaired NE clearance in obesity.

© 2013 Elsevier Inc. All rights reserved.

KEYWORDS:

BMI; Human; Norepinephrine; Obesity; PET; [(11)C]-MRB

PMID:
24121204
[PubMed - indexed for MEDLINE]
PMCID:
PMC3947246
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk